Skip to main content
Veterinary Medicines

Ultrapen LA 300 mg/ml Suspension for Injection

Authorised
  • Benzylpenicillin procaine

Product identification

Medicine name:
Ultrapen LA 300 mg/ml Suspension for Injection
Active substance:
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        5
        day
    • Pig
      • Meat and offal
        7
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CE09
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • 100 ml Grade II clear glass vial, complete with nitryl bung and aluminium cap.
  • 50 ml Grade II clear glass vial, complete with nitryl bung and aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22664/045/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."